Brief: Xvivo Perfusion Q3 Net Income Rises To SEK 4.9 Million
Oct 24 (Reuters) - Xvivo Perfusion AB XVIVO.ST :
* GOOD GROWTH AND NEW IMPORTANT XPS CLINICS
* Q3 NET SALES OF NON-DURABLE GOODS IN QUARTER AMOUNTED TO
SEK
50.1 (40.3) MILLION
* Q3 NET INCOME AMOUNTED TO SEK 4.9 (0.1) MILLION
Source text for Eikon: ID:nWkr3Cqfp4
Further company coverage: XVIVO.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Xvivo Perfusion AB
See all newsSweden's XVIVO Q3 revenue beat expectations on thoracic sales
Brief: Xvivo Q3 EBIT SEK 28 Million
Brief: Xvivo Receives CE Certificates For Heart Preservation Technology
Brief: XVIVO Gets FDA Approval For Additional Patient Enrollment
Sweden's XVIVO Q2 sales beat estimates, helped by thoracic segment strength